Table 3 Inclusion and Exclusion of the Bolinder Cohort in Karolinska Institute Studies
From: The scientific foundation for tobacco harm reduction, 2006-2011
Year | First Author [Ref] | Bolinder In/Out | Major Findings (RR) |
|---|---|---|---|
1994 | Bolinder [14] | In | All CV disease (1.4), All causes (1.4) |
2005 | Odenbro [15] | In | Skin SCC (0.64) |
2007 | Luo [8] | Out | Pancreatic cancer (2.0) |
2007 | Odenbro [16] | In | Melanoma (0.65) |
2007 | Fernberg [17] | In | Leukemia, MM (0.81* - 1.24*) |
2007 | Hergens [18] | Out | MI (0.91*), fatal MI (1.28) |
2008 | Zendehdel [19] | In | Esophageal SCC (3.5) Non cardia stomach cancer (1.4) |
2008 | Hergens [20] | Out | Stroke (1.02*), fatal stroke (1.27*) |
2008 | Hergens [21] | Out | Hypertension (1.23 - 1.39) |
2010 | Carlens [22] | Out | Inflammatory diseases (0.9* - 1.1*) |
2011 | Nordenvall [23] | In | Colon, rectal, anal cancer (1.05*, 1.08*, 0.61*) |